Coripharma is a European pharmaceutical company, built on solid heritage. Our experienced team offers out-licensing and contract manufacturing services to pharmaceutical companies. Coripharma specializes in generic pharmaceutical products, solid oral dosage forms.

Coripharma

The full report is now available on our website, where stakeholders can explore our initiatives and learn about the tangible outcomes of our sustainability efforts.

Sustainability_Coripharma 2024.pdf

Coripharma is pleased to announce the release of its third annual sustainability report, highlighting the continued progress in our efforts to promote environmental sustainability and social responsibility across all operations.

This year’s report outlines the ongoing steps we’ve taken to reduce our carbon footprint, enhance sustainable practices, and create a positive impact on the environment and society. We are committed to integrating sustainability into every aspect of our business and advancing our environmental and social responsibility goals.

Looking ahead, Coripharma will remain focused on prioritizing sustainability and responsible practices, ensuring we make an even greater impact in the years to come.

Coripharma Releases Its Third Annual Sustainability Report

As Coripharma continues its journey of growth and innovation, we are delighted to announce the addition of Unnur Vilhjálmsdóttir as the company´s Senior Legal Counsel and Compliance Officer

Unnur brings extensive experience to this role, having previously worked at Controlant, where she provided legal counsel on governance, corporate matters and compliance, as well as overseeing commercial agreements. Before joining Controlant, Unnur served as Head of Legal at Omnio Group Limited, a UK-based financial technology company, where she advised on governance, disputes, and legal matters across the organization. Unnur also has a strong background from her time at Valitor, where she was responsible for  governance and various legal matters for the company and its subsidiaries in the UK and Denmark. As Valitor’s corporate secretary for the group’s board and sub-committees, she provided legal support to the board, CEO, and senior management.

Unnur shared her excitement about joining Coripharma:

"I am excited to take on the responsibility for legal and compliance at Coripharma. I look forward to facing the challenges ahead and contributing to the company’s continued growth and success."

Unnur’s appointment represents a significant strengthening of the Coripharma team, and we are thrilled to have her on board.

Unnur Vilhjálmsdóttir joins Coripharma as Senior Legal Counsel and Compliance Officer

Coripharma proudly announces the completion of the 16th dossier from its own development, marking a significant milestone in the company’s journey of innovation and excellence.

Lisdexamphetamine is based on the reference product Elvanse®, commonly prescribed for managing attention deficit disorder (ADHD).

This achievement is a testament to the outstanding efforts of the R&D team and the seamless collaboration within Coripharma. The timing couldn’t be better, as the secured DCP slot in January 2025 strategically positions our partners for successful market entry.

With this milestone, Coripharma reaffirms its dedication to development of high-quality generics and strengthens its global partnerships.

Coripharma Completes Lisdexamphetamine Dossier, Secures DCP Slot for January 2025

This is a significant milestone for Coripharma which now has an annual CMO capacity of over 1.5bn tablets.  Preparations for starting manufacturing are on schedule which calls for the first batches to be released in Hafnarfjordur before year end.

Coripharma has now completed its purchase of the Actavis manufacturing site in Iceland.

About us

Services

Sustainability

Careers

Acquisition completed

More news

Coripharma Releases Its Third Annual Sustainability Report

Unnur Vilhjálmsdóttir joins Coripharma as Senior Legal Counsel and Compliance Officer

Coripharma Completes Lisdexamphetamine Dossier, Secures DCP Slot for January 2025

+354 4206700